Rising costs lead to DM program aimed at TMD
Related Experiment Video
Updated: Oct 9, 2026

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
Published on: August 11, 2015
Abstract:
Pain and other symptoms associated with the jaw are nothing new, but some health care organizations have noticed that costs and complaints related to these problems are on the rise, and there continues to be controversy over where such problems belong: in the hands of a dentist or a physician. Further, many experts believe patients with TMD are too often treated more aggressively than need be, and that a step-by-step approach, emphasizing conservative strategies first, is long overdue.
Related Concept Videos
Therapeutic Drug Monitoring: Overview and Classification
Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring: Drug Analysis Methods
